Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: September 2011
-
A number of CLE events addressing the Leahy-Smith America Invents Act have been scheduled for the next few weeks. These events include: The American Intellectual Property Law Association (AIPLA) will be offering a web-based program entitled "Practical Implications: The Impact of the America Invents Act" on October 5, 2011 from 12:30 – 2:00 pm (Eastern). …
-
The Intellectual Property Law Association of Chicago (IPLAC) will be offering a panel discussion entitled "Therasense: Will the Tide Finally Turn in the Plague of Dubious Inequitable Conduct Claims and Reference Flooding?" on October 6, 2011 from 6:00 to 7:00 pm (CT) at the offices of Nixon Peabody in Chicago, IL. The panel discussion will…
-
By James DeGiulio — Earlier this year, the U.S. Food and Drug Administration declared that it would release regulatory guidelines for biosimilars by the end of 2011, and since the FDA's announcement, the biotechnology industry has eagerly awaited the agency's insight on gaining approval for biosimilars in a potentially multi-billion dollar U.S. market. Just last…
-
By Donald Zuhn — The U.S. Patent and Trademark Office continues the process of implementing the many changes to U.S. patent law brought about by the enactment of the Leahy-Smith America Invents Act (AIA) on September 16. In one of its more recent steps, the Office issued a notice in the Federal Register (76 Fed.…
-
By Donald Zuhn — In anticipation of yesterday's implementation of the 15% surcharge on certain patent fees pursuant to § 11 of the Leahy-Smith America Invents Act, the U.S. Patent and Trademark Office issued a press release and Federal Register notice (76 Fed. Reg. 59115) last week regarding the patent fees changes. In the Federal…
-
By Donald Zuhn — Five months after postponing the launch date of the prioritized examination (or Track I) portion of the Enhanced Examination Timing Control Procedures Initiative, the U.S. Patent and Trademark Office announced on Friday that it would begin accepting requests for prioritized examination today. The program was postponed in April due to "funding…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. ISIS Pharmaceuticals, Inc. v. Santaris Pharma A/S Corp. et al.3:11-cv-02214; filed September 22, 2011 in the Southern District of California • Plaintiff: ISIS Pharmaceuticals, Inc.• Defendants: Santaris Pharma A/S Corp.; Santaris A/S Infringement of U.S.…
-
September 26-27, 2011 – Biosimilars and Biobetters*** (SMi Group) – London, UK September 26-27, 2011 – Life Sciences Business Development & Acquisitions in Emerging Markets (American Conference Institute) – New York, NYNew York, NY September 28, 2011 – The Impact of Stanford v. Roche on Private Party Transactions: Inventor Ownership and Government Rights Under Bayh-Dole…
-
American Conference Institute (ACI) will be holding its 16th annual Drug and Medical Device Litigation conference on December 5-7, 2011 in New York, NY. The conference will allow attendees to: • Strengthen class action strategies by factoring favorable recent judicial decisions into new defense tactics;• Master the challenges created by the increased focus on the…
-
Patent Exhaustion Does Not Apply to Genetically Engineered Seed By Kevin E. Noonan — Yesterday, the Federal Circuit once again upheld a judgment of infringement brought by Monsanto against a farmer who replanted its patented Roundup Ready® seed. As it had in Monsanto Co. v. McFarling, Monsanto Co. v. David, and Monsanto Co. v. Scruggs,…
Patent Docs 